Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2026-03-06 @ 1:34 PM
Study NCT ID:
NCT00841035
Status:
TERMINATED
Last Update Posted:
2017-05-19
First Post:
2009-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients
Sponsor:
University of Alabama at Birmingham
Organization: